Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2013 · 10-Q
Revenue$75.08M$75.08M+0.6% vs Q2 2012 Net Income$25.36M$25.36M−1.7% vs Q2 2012 EPS Diluted$0.69$0.69−1.4% vs Q2 2012 Gross Profit$55,263,000+0.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$31,287,000+53.1% Free Cash Flowderived$23,067,000+26.5% Margins · derivedGross margin73.6%−0.3 pt vs Q2 2012
Operating margin49.2%−1.3 pt vs Q2 2012
Net margin33.8%−0.8 pt vs Q2 2012
ended Dec 31, 2012 · filed Feb 11, 2013 · 42 d after period end